ENTA
Enanta Pharmaceuticals, Inc.NASDAQHealthcare$13.14+1.31%ClosedMarket Cap: $305.1M
As of 2026-04-06
Insider Statistics (Q1 2026)
Purchases
18
Sales
6
Buy/Sell Ratio
3.00
Total Bought
$0.00
Total Sold
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Fri Mar 13 | Vance Terry | director | Sell | 20,000 | $14.17 | 20,000 |
| Fri Mar 13 | Russell Lesley | director | Sell | 20,000 | $14.17 | 20,000 |
| Fri Mar 13 | Peterson Kristine | director | Sell | 20,000 | $14.17 | 20,000 |
| Fri Mar 13 | Hata Yujiro S | director | Sell | 20,000 | $14.17 | 20,000 |
| Fri Mar 13 | FOLETTA MARK G | director | Sell | 20,000 | $14.17 | 20,000 |
| Fri Mar 13 | CARTER BRUCE L A | director | Sell | 20,000 | $14.17 | 20,000 |
| Fri Feb 13 | Kowalsky Matthew Paul | officer: Chief Legal Officer | Sell | 4,175 | $0.00 | 5,493 |
| Fri Feb 13 | Kowalsky Matthew Paul | officer: Chief Legal Officer | Sell | 1,902 | $14.25 | 3,591 |
| Fri Feb 13 | Kowalsky Matthew Paul | officer: Chief Legal Officer | Sell | 1,318 | $0.00 | 1,318 |
| Fri Feb 13 | Luu Brendan | officer: Chief Business Officer | Sell | 4,987 | $0.00 | 44,891 |